Niimura Takahiro

Affiliation and department：
Research theme for competitive and other funds (10)：

2024 - 2027 抗VEGF療法の治療効果向上を目指した最適な支持療法薬の解明
2023 - 2026 リアルワールドデータを活用した薬剤性腎障害に対する新規予防戦略の開発
2022 - 2025 Gendered innovation in cancer chemotherapy - real world data driven pharmacological research
2022 - 2025 大規模医療情報を用いた薬剤性心筋炎治療薬の探索および有効性の検証
2021 - 2024 Elucidation of the relationship between infectious diseases and aortic diseases by big data analysis and in vivo experiments

Show all

Papers (93)：

Fuka Aizawa, Haruna Kajimoto, Ami Okabayashi, Daishi Moriyama, Kenta Yagi, Shimon Takahashi, Yuhei Sonoda, Takahiro Shibata, Mitsuhiro Goda, Takahiro Niimura, et al. Statins ameliorate oxaliplatin- and paclitaxel-induced peripheral neuropathy via glutathione-S-transferase. Neurochemistry international. 2024. 105863-105863
Koji Miyata, Yuki Izawa-Ishizawa, Kaito Tsujinaka, Honoka Nishi, Syuto Itokazu, Tatsumi Miyata, Masateru Kondo, Toshihiko Yoshioka, Takahiro Niimura, Fuka Aizawa, et al. Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024. 179. 117418-117418
Naoki Okamoto, Kenta Yagi, Sayaka Imawaka, Mayu Takaoka, Fuka Aizawa, Takahiro Niimura, Mitsuhiro Goda, Koji Miyata, Kei Kawada, Yuki Izawa-Ishizawa, et al. Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance. Pharmacology research & perspectives. 2024. 12. 4. e1214
Kei Kawada, Tomoaki Ishida, Hitoshi Fukuda, Yuki Hyohdoh, Toru Kubo, Tomoyuki Hamada, Yuichi Baba, Toshinobu Hayashi, Fuka Aizawa, Kenta Yagi, et al. Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan. Frontiers in Cardiovascular Medicine. 2024. 11
Yurie Oka, Jun Matsumoto, Tatsuaki Takeda, Naohiro Iwata, Takahiro Niimura, Aya Fukuma Ozaki, Kensuke Bekku, Hirofumi Hamano, Motoo Araki, Keisuke Ishizawa, et al. Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study. International journal of clinical pharmacy. 2024

ｍore...

MISC (34)：

友近七海, 相澤風花, 薗田悠平, 西橋彩香, 宮内奏穂, 合田光寛, 八木健太, 新村貴博, 石澤有紀, 朝田瑞穂, et al. 実験的多発性硬化症モデルマウスに対するウルソデオキシコール酸の治療効果の検討. 次世代を担う若手のための創薬・医療薬理シンポジウムプログラム・要旨集. 2023. 2023
埜本隼助, 朝田瑞穂, 朝田瑞穂, 見神尊修, 合田光寛, 合田光寛, 薗田悠平, 薗田悠平, 高橋志門, 高橋志門, et al. Search for steroid-related drugs that inhibit multiple sclerosis using the FDA Adverse Event Reporting System database. 日本薬学会年会要旨集(Web). 2023. 143rd
川田敬, 川田敬, 石田智滉, 福田仁, 兵頭勇己, 浜田知幸, 久保亨, 相澤風花, 相澤風花, 八木健太, et al. 機械学習解析を用いた心不全治療薬の年齢別有効性の検討-高知急性非代償性心不全レジストリ研究より-. 日本臨床薬理学会学術総会抄録集(Web). 2023. 44th
八木健太, 相澤風花, 新村貴博, 石澤有紀, 濱野裕章, 合田光寛, 座間味義人, 石澤啓介, 八木健太, 相澤風花, et al. VEGF発現にプロトンポンプ阻害剤が与える影響. 日本循環薬理学会口演要旨集. 2023. 32nd
新村貴博, 運天拡人, 濱野裕章, 内田和志, 宮田晃志, 合田光寛, 八木健太, 相澤風花, 石澤有紀, 座間味義人, et al. PD-1ノックアウトマウスを用いた免疫チェックポイント阻害剤関連心筋炎の新規病態モデル開発. 日本循環薬理学会口演要旨集. 2023. 32nd

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page